Induction of interferon-γ from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-α and tumour necrosis factor-α

被引:66
作者
Marshall, JD [1 ]
Heeke, DS [1 ]
Abbate, C [1 ]
Yee, P [1 ]
Van Nest, G [1 ]
机构
[1] Dynavax Technol Corp, Berkeley, CA 94710 USA
关键词
CpG DNA; interferon-alpha; interferon-gamma; natural killer cells; plasmacytoid dendritic cells;
D O I
10.1111/j.1365-2567.2005.02261.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunostimulatory sequences (ISS) that contain CpG motifs have been demonstrated to exert antipathogen and antitumour immunity in animal models through several mechanisms, including the activation of natural killer (NK) cells to secrete interferon-gamma (IFN-gamma) and to exert lytic activity. Since NK cells lack the ISS receptor TLR9, the exact pathway by which NK cells are activated by ISS is unclear. We determined that ISS-induced IFN-gamma from NK cells is primarily dependent upon IFN-alpha release from plasmacytoid dendritic cells (PDCs), which directly activates the NK cell. However, further analysis indicated that other PDC-released soluble factor(s) may contribute to IFN-gamma induction. Indeed, tumour necrosis factor-alpha (TNF-alpha) was identified as a significant contributor to ISS-mediated activation of NK cells and was observed to act in an additive fashion with IFN-alpha in the induction of IFN-gamma from NK cells and to up-regulate CD69 expression on NK cells. This activity of TNF-alpha, however, was dependent upon the presence of PDC-derived factors such as type I interferon. These results illustrate an important function for type I interferon in innate immunity, which is not only to activate effectors like NK cells directly, but also to prime them for enhanced activation by other factors such as TNF-alpha.
引用
收藏
页码:38 / 46
页数:9
相关论文
共 48 条
  • [1] Adolf G R, 1995, Mult Scler, V1 Suppl 1, pS44
  • [2] Baines J, 2003, CLIN CANCER RES, V9, P2693
  • [3] Bohle B, 1999, EUR J IMMUNOL, V29, P2344, DOI 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO
  • [4] 2-R
  • [5] Carpentier AF, 2000, CLIN CANCER RES, V6, P2469
  • [6] Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production
    Chalifour, A
    Jeannin, P
    Gauchat, JF
    Blaecke, A
    Malissard, M
    N'Guyen, T
    Thieblemont, N
    Delneste, Y
    [J]. BLOOD, 2004, 104 (06) : 1778 - 1783
  • [7] CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
    Davis, HL
    Suparto, I
    Weeratna, R
    Jumintarto
    Iskandriati, D
    Chamzah, S
    Ma'ruf, A
    Nente, C
    Pawitri, D
    Krieg, AM
    Heriyanto
    Smits, W
    Sajuthi, D
    [J]. VACCINE, 2000, 18 (18) : 1920 - 1924
  • [8] Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge
    Dumais, N
    Patrick, A
    Moss, RB
    Davis, HL
    Rosenthal, KL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (08) : 1098 - 1105
  • [9] IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences
    Duramad, O
    Fearon, KL
    Chan, JH
    Kanzler, H
    Marshall, JD
    Coffman, RL
    Barrat, FJ
    [J]. BLOOD, 2003, 102 (13) : 4487 - 4492
  • [10] CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization
    Encke, J
    Putlitz, JZ
    Stremmel, W
    Wands, JR
    [J]. ARCHIVES OF VIROLOGY, 2003, 148 (03) : 435 - 448